Ullevaal University Hospital

oslo-universitetssykehus.no

Total trials

77

Active

0

Phase 3

11

Total enrollment

14,707

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Pain, Postoperative4
  • Femoral Neck Fractures4
  • Quality of Life3
  • Postoperative Pain3
  • Low Back Pain3
  • Hip Osteoarthritis3
  • Hypertension2
  • Coxarthrosis2

Frequently asked questions about Ullevaal University Hospital

How many clinical trials does Ullevaal University Hospital have on ClinicalTrials.gov?
Ullevaal University Hospital is listed as the lead sponsor on 77 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
How many of Ullevaal University Hospital's trials are in Phase 3?
11 of Ullevaal University Hospital's trials are in Phase 3.
What therapeutic areas does Ullevaal University Hospital focus on?
Ullevaal University Hospital's most-studied conditions on ClinicalTrials.gov are Pain, Postoperative, Femoral Neck Fractures, Quality of Life, Postoperative Pain, Low Back Pain.